CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry.

OBJECTIVE The purpose of this study was to evaluate with MRI the involvement of gray matter and white matter structures in patients with primary Sjögren syndrome. SUBJECTS AND METHODS Fifty-three patients with primary Sjögren syndrome, 18 age- and disease duration-matched patients with systemic sclerosis, and 35 age-matched control subjects were examined for differences in white matter hyperintensities (WMHIs) detected on FLAIR MR images. Differences in brain volume between patients with primary Sjögren syndrome and controls were studied by application of voxel-based morphometry to a 3D T1-weighted sequence. RESULTS WMHIs were observed in 38 of the 53 patients with primary Sjögren syndrome, six of 18 patients with systemic sclerosis, and 17 of 35 controls. The numbers of WMHIs 2 mm or larger and the number smaller than 2 mm were higher in patients with primary Sjögren syndrome than in controls (≥ 2 mm, p = 0.004; < 2 mm, p < 0.001). No significant difference was observed in the number of WMHIs in primary Sjögren syndrome patients and that in systemic sclerosis patients. After control for age, a positive relation was found between disease duration and total number of WMHIs (p = 0.037) and number of WMHIs 2 mm or larger (p = 0.023) in patients with primary Sjögren syndrome. In comparison with the controls, patients with primary Sjögren syndrome had decreased gray matter volume in the cortex, deep gray matter, and cerebellum. Associated loss of white matter volume was observed in areas corresponding to gray matter atrophy and in the corpus callosum (p < 0.05). CONCLUSION Patients with primary Sjögren syndrome have WMHIs and gray and white matter atrophy, probably related to cerebral vasculitis.

[1]  L. Astrakas,et al.  Shifting from region of interest (ROI) to voxel-based analysis in human brain mapping , 2010, Pediatric Radiology.

[2]  L. Astrakas,et al.  Voxel‐Based Morphometry and Voxel‐Based Relaxometry in Parkinsonian Variant of Multiple System Atrophy , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[3]  Li Min Li,et al.  Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus , 2007, NeuroImage.

[4]  M. Argyropoulou,et al.  Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. , 2006, Arthritis and rheumatism.

[5]  Wang Min,et al.  Leuko araiosis , 2006 .

[6]  Xiaohua Chen,et al.  Gray matter reduction is correlated with white matter hyperintensity volume: A voxel-based morphometric study in a large epidemiological sample , 2006, NeuroImage.

[7]  Fumiaki Tanaka,et al.  The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. , 2005, Brain : a journal of neurology.

[8]  S. Pillemer,et al.  Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging , 2004 .

[9]  P. Vermersch,et al.  Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients , 2004, Medicine.

[10]  H. C. Chui,et al.  White matter lesions impair frontal lobe function regardless of their location , 2004, Neurology.

[11]  H. Moutsopoulos,et al.  Central nervous system involvement in Sjögren’s syndrome , 2004, Annals of the rheumatic diseases.

[12]  Henry Brodaty,et al.  Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI , 2004, NeuroImage.

[13]  L. Pierot,et al.  Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases , 2004, Neuroradiology.

[14]  M. Mataró,et al.  Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren Syndrome , 2003, Journal of neurology.

[15]  W. S. Huang,et al.  Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report , 2003, Rheumatology International.

[16]  T. Kaji,et al.  Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings , 2002, Neuroradiology.

[17]  Karl J. Friston,et al.  Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.

[18]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[19]  Sandra E. Black,et al.  Callosal Atrophy Correlates with Temporal Lobe Volume and Mental Status in Alzheimer's Disease , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[20]  Yukito Shinohara,et al.  Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging , 2000, Journal of the Neurological Sciences.

[21]  J. Dumas,et al.  Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. , 1999, Annales de medecine interne.

[22]  C. Anderson,et al.  Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. , 1999, The Journal of rheumatology.

[23]  L. Caniatti,et al.  Neurological Involvement in Primary Sjo¨gren’s Syndrome: Clinical and Instrumental Evaluation in a Cohort of Italian Patients , 1999, Clinical Rheumatology.

[24]  P. Chieng,et al.  Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  B Horwitz,et al.  Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. , 1998, Archives of neurology.

[26]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[27]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[28]  N. Patronas,et al.  Anti‐Ro(SS‐A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS‐SS) , 1994, Neurology.

[29]  Alexander El Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. , 1993 .

[30]  Alexander El Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. , 1992 .

[31]  R. Molina,et al.  Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome. , 1992, The American journal of medicine.

[32]  R D Tien,et al.  Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. , 1992, AJR. American journal of roentgenology.

[33]  A. Delacourte,et al.  Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? , 1991, Journal of neurology, neurosurgery, and psychiatry.

[34]  A. Drosos,et al.  Neuropsychiatric abnormalities in primary Sjögren's syndrome. , 1989, Clinical and experimental rheumatology.

[35]  O. Selnes,et al.  Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. , 1988, Annals of internal medicine.

[36]  R. Bone,et al.  Primary Sjogren syndrome: clinical and immunopathologic features. , 1984, Seminars in arthritis and rheumatism.

[37]  E. Alexander,et al.  Neurologic Complications of Primary Sjögren's Syndrome , 1982, Medicine.